279 related articles for article (PubMed ID: 2413181)
1. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
2. Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.
Hayes DF; Sekine H; Ohno T; Abe M; Keefe K; Kufe DW
J Clin Invest; 1985 May; 75(5):1671-8. PubMed ID: 3889057
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
4. CA125 antigen levels in obstetric and gynecologic patients.
Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.
Lundy J; Thor A; Maenza R; Schlom J; Forouhar F; Testa M; Kufe D
Breast Cancer Res Treat; 1985; 5(3):269-76. PubMed ID: 2992647
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
Sekine H; Ohno T; Kufe DW
J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199
[TBL] [Abstract][Full Text] [Related]
7. Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells.
Abe M; Kufe D
J Cell Physiol; 1986 Jan; 126(1):126-32. PubMed ID: 2418036
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.
Hayes DF; Mesa-Tejada R; Papsidero LD; Croghan GA; Korzun AH; Norton L; Wood W; Strauchen JA; Grimes M; Weiss RB
J Clin Oncol; 1991 Jul; 9(7):1113-23. PubMed ID: 2045853
[TBL] [Abstract][Full Text] [Related]
9. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
[TBL] [Abstract][Full Text] [Related]
10. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
11. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.
Perey L; Hayes DF; Maimonis P; Abe M; O'Hara C; Kufe DW
Cancer Res; 1992 May; 52(9):2563-8. PubMed ID: 1373671
[TBL] [Abstract][Full Text] [Related]
12. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes DF; Zurawski VR; Kufe DW
J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor-associated antigen detected by the murine monoclonal antibody CF511 in human epithelial ovarian carcinoma.
Murae M; Ohkawa K; Kimura E
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1841-8. PubMed ID: 2687410
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC
Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
16. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the DF3 human breast carcinoma-associated protein.
Abe M; Kufe D
Cancer Res; 1989 Jun; 49(11):2834-9. PubMed ID: 2470498
[TBL] [Abstract][Full Text] [Related]
19. Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen.
Hayes DF; Sekine H; Marcus D; Alper CA; Kufe DW
Blood; 1988 Feb; 71(2):436-40. PubMed ID: 3337905
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
